Dr. Peter O'Donnell presented patient-reported outcomes (PROs) from the phase III KEYNOTE-905/EV-303 trial evaluating perioperative enfortumab vedotin (EV) plus pembrolizumab in cisplatin-ineligible ...
If you've still got an old PlayStation 1 sitting around gathering dust, you could be using it to make music with a piece of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results